Catching Up with Catching Cancer Early: Reflections from a TME Webinar
Adopting the right technology and innovation can yield improved patient access and outcomes as the industry navigates the backlog of elective procedures from screening to surgery.
Using Automated Breast Density Assessment for Triage
Personalized screening recognizes that every woman is different, with varied mammographic sensitivity and risk of developing breast cancer.
What is Residual Breast Density and Why it Matters in the Tyrer-Cuzick Risk Model
Breast density is an independent risk factor associated with the development of breast cancer.1, 2, 3, 4 Adding breast density to risk calculation has been shown to more accurately predict...
Understanding the Use of Competing Mortality in Risk Assessment
To understand the risk of developing a disease such as breast cancer, studies test the predictive value of risk factors.
Guide to Best Practices for Clinical Tyrer-Cuzick Risk Assessment
Breast screening is rapidly moving into an era of personalized care, where prevention, early detection, and treatment are guided by risk assessment.
How to Get Your Patients on Their Best Screening Pathway
The need for greater participation in breast cancer screening programs cannot be overlooked. An estimated 1 in 8 women will develop breast cancer in her lifetime.
Tyrer-Cuzick 8: Adding Breast Density to Breast Cancer Prediction
The upcoming version of the Tyrer-Cuzick breast cancer risk prediction model incorporates breast density
Review: Association between breast cancer, breast density, and body adiposity evaluated by MRI
Association between breast cancer, breast density, and body adiposity evaluated by MRI
Review: Association of breast density with breast cancer risk in screening mammography
Association of breast density with breast cancer risk in screening mammography
